1. Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial. Issue 5 (9th March 2022) Authors: Cid, Maria C; Unizony, Sebastian H; Blockmans, Daniel; Brouwer, Elisabeth; Dagna, Lorenzo; Dasgupta, Bhaskar; Hellmich, Bernhard; Molloy, Eamonn; Salvarani, Carlo; Trapnell, Bruce C; Warrington, Kenneth J; Wicks, Ian; Samant, Manoj; Zhou, Teresa; Pupim, Lara; Paolini, John F Journal: Annals of the rheumatic diseases Issue: Volume 81:Issue 5(2022) Page Start: 653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗